Introduction {#Sec1}
============

The demand for therapeutic proteins, i.e. monoclonal antibodies, has been forecast to exceed production capacities (Werner [@CR56]). Moderate increases in product titers and yields are expected to result in significant savings in capital investment and consumer costs (Werner [@CR56]). Over the last decade product titers have increased from ∼20 mg l^−1^ to 2 g l^−1^ (Werner [@CR56]; Wurm [@CR59]). These improvements are largely attributable to increases in viable cell densities. However, cell specific productivities remained nearly constant during this time (Wurm [@CR59]).

To improve cell specific productivities the bottleneck for heterologous protein secretion has to be identified and resolved. In expression systems exploiting multiple gene copies or strong promoters the amount of secreted heterologous protein does not increase proportionally with gene copy number (Schröder [@CR40]), messenger ribonucleic acid (mRNA) (Schröder et al. [@CR43]), or even the intracellular amount of the heterologous protein (Schröder and Friedl [@CR41]). In these cells, the protein accumulates in intracellular aggregates (Schröder and Kaufman [@CR42]), associates with the molecular chaperone heavy chain-binding protein (BiP)/glucose-regulated protein of 78 kDa (GRP78)/karyogamy 2 protein (Kar2p) (Schröder and Kaufman [@CR42]), and induces dilation of the endoplasmic reticulum (ER) (Dorner et al. [@CR7]; Gennaro et al. [@CR12]). Therefore, exit of the correctly folded polypeptide chain from the ER is the rate-limiting step for heterologous protein secretion. I will discuss strategies to improve cell specific productivities by engineering protein folding in the ER and signal transduction pathways activated by overexpression of heterologous proteins.

Protein folding in the ER {#Sec2}
=========================

The ER-resident protein folding machinery has four components: (1) Molecular chaperones assisting other proteins to fold, (2) enzymes such as protein disulfide isomerases (PDIs) and *cis-trans* peptidyl prolyl isomerases (PPIs), (3) a degradation machinery, and (4) signal transduction pathways that co-ordinate protein folding demand with capacity. At least three hierarchically organized chaperone systems operate in the ER, the heat shock protein of 70 kDa (HSP70) chaperones BiP and luminal HSP seventy 1 protein (Lhs1p)/chaperone in the ER 1 protein/Ssi1p/GRP170/oxygen-regulated protein of 150 kDa (ORP150), the HSP90 chaperone GRP94/adenotin/endoplasmin/tumor rejection antigen glycoprotein of 96 kDa (gp96)/ER protein of 99 kDa/HSP108/Ca^2+^-binding protein 4/protein kinase of 80 kDa, and the lectin chaperones calnexin/p88, calreticulin/Ca^2+^-binding protein of 63 kDa (CAB-63)/calregulin/Ca^2+^-regulated protein of 55 kDa (CRP55)/high affinity Ca^2+^-binding protein (HACBP), and calmegin/calnexin-t (Fig. [1](#Fig1){ref-type="fig"}). BiP works on completely unfolded polypeptide chains and translocates nascent polypeptide chains into the ER, whereas GRP94 and the lectin chaperones work on partially folded substrates. Fig. 1Hierarchy of chaperone systems in the ER. Abbreviations: Glc =[ d]{.smallcaps}-glucose, P~i~ = inorganic phosphate ($\documentclass[12pt]{minimal}
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BiP consists of an *N*-terminal ATPase domain and a *C*-terminal substrate binding domain. BiP cycles through rounds of adenosine triphosphate (ATP) hydrolysis and adenosine diphosphate (ADP) ATP exchange (Fig. [1](#Fig1){ref-type="fig"}), which makes BiP a chaperone foldase (Winter and Jakob [@CR58]). At least six DnaJ or HSP40 co-chaperones stimulate the ATPase activity of BiP and two growth after phage induction E (GrpE) co-chaperones the ADP ATP exchange reaction. In the ADP-bound form BiP has high affinity for unfolded substrates. Substrates bound to BiP are conformationally locked. ADP ATP exchange decreases the affinity of BiP for unfolded substrates. Substrate binding stimulates the ATPase activity of BiP. Thus, protein folding requires ATP (Dorner and Kaufman [@CR6]). BiP and Lhs1p coordinate their activities. Lhs1p is a nucleotide exchange factor for BiP, and BiP stimulates the ATPase activity of Lhs1p (Steel et al. [@CR47]).

Cytosolic HSP90 chaperones are ATP-consuming chaperone foldases (Fig. [1](#Fig1){ref-type="fig"}) regulated by several co-chaperones that affect its ATPase activity, load substrates onto HSP90 chaperones, assist in protein folding, and target substrates to degradation pathways (Strudwick and Schröder [@CR48]). GRP94 co-chaperones have not been identified, but other ER luminal chaperones found in complexes with GRP94 may be GRP94 co-chaperones. The *K*~M~ value of GRP94 for ATP is ∼100 μM and its intrinsic ATPase activity is barely detectable. These data indicate that GRP94 may be a chaperone holdase, a chaperone that binds to unfolded proteins, but does not cycle through ATP hydrolysis cycles. A drop of adenine nucleoside concentrations in stress situations may activate GRP94 (Rosser et al. [@CR38]).

The lectin chaperones share an *N*-terminal globular oligosaccharide-binding domain and a *C*-terminal extended hairpin loop, the P domain, which provides the chaperone function (Strudwick and Schröder [@CR48]). Calnexin and calmegin are transmembrane proteins. Calreticulin is a soluble protein. Most proteins entering the ER are glycosylated by addition of the oligosaccharide Glc~3~Man~9~GlcNAc~2~ (Glc = [d]{.smallcaps}-glucose, Man =[ d]{.smallcaps}-mannose, GlcNAc = *N*-Acetyl-2-[d]{.smallcaps}-glucosamine). α-Glucosidases I and II rapidly remove the two terminal [d]{.smallcaps}-glucose residues. Calnexin and calreticulin bind to this monoglucosylated oligosaccharide. Removal of the third [d]{.smallcaps}-glucose moiety by α-glucosidase II releases the protein from calnexin/calreticulin. Reglucosylation of unfolded proteins by uridine diphosphate (UDP)-glucose:glycoprotein glucosyl transferase (UGGT) triggers repeated interactions with calnexin/calreticulin (Fig. [1](#Fig1){ref-type="fig"}). This reglucosylation reaction consumes UDP-glucose. Therefore, the calnexin chaperones are chaperone foldases. The *Saccharomyces cerevisiae* genome encodes a calnexin homolog, but no homolog for UGGT, suggesting that the lectin chaperones may also function as holdases. Demannosylation of *N*-linked oligosaccharides trigger export of proteins to the Golgi complex or their targeting for retrotranslocation into the cytosol and proteasomal degradation (Lederkremer and Glickman [@CR27]; Ruddock and Molinari [@CR39]).

An expanding family of PDIs catalyzes the formation and isomerization of disulfide bonds. Disulfide bond formation requires the regeneration of oxidized PDI catalyzed by the flavin adenine dinucleotide (FAD)-dependent oxidases ER oxidation 1 protein (Ero1p)/ERO1-Lα, ERO1-Lβ and essential for respiration and viability 2 protein (Erv2p) (Fig. [2](#Fig2){ref-type="fig"}). The final electron acceptor is molecular oxygen. Oxidative protein folding accounts for ∼25% of all reactive oxygen species (ROS) formed in a cell (Tu and Weissman [@CR52]) and is increased by ER stress (Haynes et al. [@CR15]). Disulfide bond isomerization is independent of the Ero1p oxidases. Reduced glutathione provides reducing equivalents to remove incorrectly formed disulfide bonds. PDI has chaperone holdase activity that is independent of its protein disulfide isomerase activity (Wilkinson and Gilbert [@CR57]) and redox-regulated foldase activity (Tsai et al. [@CR51]). Fig. 2Disulfide bond formation and isomerization reactions catalyzed by PDI

Slowly folding proteins or folded incompetent proteins have to be removed from chaperone cycles to prevent them from poisoning the protein folding machinery. This is achieved by targeting these proteins for retrotranslocation into the cytosol and degradation by the proteasome in a process called ER associated protein degradation (ERAD) (Yoshida [@CR60]) (Fig. [3](#Fig3){ref-type="fig"}). Proteins destined for ERAD are recognized by BiP, PDI, and lectin sensors such as ER-degradation enhancing α-mannosidase-like proteins 1--3 (EDEM1--3)/homologous to mannosidase I 1 protein (Htm1p)/mannosidase-like 1 protein (Mnl1p) and osteosarcoma-9 (OS-9)/yeast OS-9 homolog protein (Yos9p) (Gauss et al. [@CR10]). The lectin sensor EDEM extracts unfolded proteins from the calnexin cycle. ERAD substrates are then retrotranslocated into the cytosol via the secretory 61 (SEC61) channel or a channel formed by derlin proteins, ubiquitinated by action of ubiquitin-conjugating enzymes (E2 enzymes) and ubiquitin ligases (E3 enzymes), deglycosylated, and degraded by the proteasome. Redundancy exists in the ubiquitination machinery involved in ERAD. In yeast and mammalian cells at least three distinct E2·E3 complexes are present in the ER membrane. The substrate specificities of these complexes, as well as their substrate selection rules are poorly understood. In yeast, the E3 ligase Hrd1p co-operates with Hrd3p and Yos9p to select its substrates (Gauss et al. [@CR11]). Another selection criterion is the time an unfolded protein spends in foldase cycles. In the calnexin cycle, demannosylation of *N*-linked oligosaccharides generates glycostructures recognized by lectins such as EDEM1--3. Association of cytosolic HSP70s with the nucleotide exchange factor B cell leukemia/lymphoma 2 (Bcl-2) associated athanogene protein 1 (BAG-1) (Alberti et al. [@CR1]) and of cytosolic HSP90s with the ubiquitin ligase carboxyl terminus of heat shock cognate protein of 70 kDa (HSC70) interacting protein (CHIP) (Höhfeld et al. [@CR18]) targets proteins for proteasomal degradation. Association of the DnaJ co-chaperone 58 kDa inhibitor of double-stranded RNA activated protein kinase (PKR, p58^IPK^) with HSP70 chaperones at the translocation pore targets proteins, whose translocation into the ER is stalled, for proteasomal degradation (Oyadomari et al. [@CR34]). If similar targeting mechanisms for proteins folding slowly in the BiP foldase cycle exist, is currently unknown. Fig. 3ER associated protein degradation. The exact nature of the retrotranslocation channel is unknown. The list of E2 and E3 enzymes catalyzing ubiquitination of ERAD substrates is not exhaustive. Abbreviations: NEF = HSP70 co-chaperone, Ub = ubiquitin

Engineering of chaperone machineries {#Sec3}
====================================

Engineering of chaperone holdases should be straightforward. Holdases hold onto an unfolded protein and act in an equimolar ratio to the unfolded substrate, but are unable to support folding reactions. Holdases may provide a buffer capacity to prevent aggregation of unfolded proteins. Co-overexpression of chaperone foldases may be beneficial to overexpression of holdases (Smith et al. [@CR46]; Zhang et al. [@CR63]). Overexpression data for calnexin/calreticulin and PDI are most easily explained by assuming that this buffer capacity is increased. Calnexin or calreticulin overexpression generally improved heterologous protein secretion (Chung et al. [@CR3]; Conesa et al. [@CR4]; Kato et al. [@CR22]). Overexpression of one cycle constituent should not increase cycle capacity, if this constituent is not limiting, and if constituent levels are not co-regulated. The hypothesis that calnexin or calreticulin are limiting for the calnexin cycle seems unlikely, because of the high abundance of these proteins. Alternatively, overexpression of calnexin or calreticulin may inactivate lectins such as EDEM (Molinari et al. [@CR30]; Oda et al. [@CR32]), which target unfolded proteins for ERAD. Further, elevated calnexin or calreticulin levels not supported by concomitant increases in activities of other calnexin cycle components, may convert these surplus amounts of calnexin and calnexin into holdases or inactive chaperones.

PDI overexpression increased secretion of some, but not all, heterologous proteins (Butz et al. [@CR2]; Damasceno et al. [@CR5]; Inan et al. [@CR20]; Kato et al. [@CR22]; Mohan et al. [@CR29]; Schröder [@CR40]; Zhang et al. [@CR63]). PDI overexpression provides increased holdase activity in the ER. For example, overexpression of catalytically inactive PDI improved heterologous protein secretion (Hayano et al. [@CR14]). PDI overexpression also improved secretion of heterologous proteins containing no disulfide bonds (Powers and Robinson [@CR36]; Smith et al. [@CR46]; Vad et al. [@CR53]). Substrate selectivity of PDI may explain why PDI overexpression failed to increase heterologous protein secretion in some studies (Butz et al. [@CR2]; Damasceno et al. [@CR5]; Mohan et al. [@CR29]; Schröder [@CR40]). If this is the case, co-expression of an alternative holdase, i.e. GRP94, may yield more consistent results for different heterologous proteins. Alternatively, increased rates of disulfide bond formation or isomerization in PDI overexpressing cells may explain increased heterologous protein secretion. As an enzyme, PDI should function at substochiometric ratios to its substrates. In disulfide bond formation, regeneration of oxidized PDI may become rate-limiting in PDI overexpressing cells. PDI is an abundant ER protein, making it unlikely that its overexpression can significantly augment its catalytic activities.

Engineering of foldases seems more difficult, because of the complex regulation of these chaperones (see above). BiP overexpression increased heterologous protein secretion for about half of the heterologous proteins studied (Chung et al. [@CR3]; Damasceno et al. [@CR5]; Dorner et al. [@CR8]; Hsu and Betenbaugh [@CR19]; Kim et al. [@CR23]; Schröder [@CR40]; Smith and Robinson [@CR45]; Zhang et al. [@CR63]), but can also have negative effects (Dorner et al. [@CR8]; Schröder [@CR40]). In cells overexpressing BiP one of its co-chaperones, Lhs1p, or ER luminal ATP may become limiting, converting BiP into a holdase or inactive chaperone. This may target proteins towards ERAD, stall translocation, convert Lhs1p into a holdase or inhibit Lhs1p. Increased BiP activity may stall the GRP94 and/or calnexin--calreticulin chaperone machineries, because of the hierarchy of ER luminal chaperone systems. This again may target heterologous proteins for ERAD. BiP overexpression attenuates the unfolded protein response (UPR, see below). Thus, BiP levels in WT and BiP overexpressing cells expressing a heterologous protein may not be dramatically different. Further, BiP overexpressing cells may experience an imbalance in their chaperone machineries, because the UPR co-ordinates expression of several chaperones. Moreover, if overexpression of BiP shifts the folding bottleneck to the GRP94 and calnexin chaperone systems, upregulation of these chaperone systems by the UPR may be blunted, because of suppression of UPR activation by elevated BiP levels.

Unfolded protein response (UPR) {#Sec4}
===============================

ER stress is the perturbation of the balance between the folding capacity and the folding demand imposed on the ER. To restore ER homeostasis, the UPR activates expression of chaperone, PDI, PPI, and ERAD genes, attenuates transcription of genes encoding secretory proteins and general translation, induces phospholipid synthesis, and induces an inflammatory response. Apoptosis is induced if these actions fail to restore ER homeostasis or in response to prolonged ER stress (Schröder and Kaufman [@CR42]).

The ER membrane of higher eukaryotes harbors at least three classes of transmembrane proteins activated by ER stress, basic leucine zipper (bZIP) transcription factors synthesized as type II transmembrane proteins, of which the best characterized are activating transcription factor 6α (ATF6α) and ATF6β/cyclic adenosine monophosphate response element binding protein (CREB)-related protein (CREB-RP)/G13, the protein kinase eukaryotic translation initiation factor 2α (eIF2α) kinase 3 (EIF2AK3)/pancreatic eIF2α kinase (PEK)/PKR-like ER kinase (PERK), and the protein kinase-endoribonucleases ER to nucleus signaling 1α (ERN1α)/inositol-requiring 1α (IRE1α) and IRE1β (Fig. [4](#Fig4){ref-type="fig"}). Several ATF6 paralogs, CREB3, CREB4, CREB-H, box B binding factor 2 (BBF2), and old astrocyte specifically induced substance (OASIS) have recently been described. In unstressed cells, these stress sensors are bound to BiP and kept in an inactive state. Upon ER stress, BiP is released coinciding with their activation. Whether BiP release is triggered by sequestration by unfolded proteins, conformational changes in the ER luminal domains, or reactivation of the BiP ATPase cycle is currently being debated (Kimata et al. [@CR24]; Shen et al. [@CR44]). ER stress also alters interactions of pro- and antiapoptotic Bcl-2 proteins at the ER membrane. These proteins regulate ER luminal Ca^2+^ homeostasis, ER morphology, ER stress signaling, and apoptosis induced in response to ER stress (Hetz [@CR17]). Fig. 4Signal transduction pathway in the UPR. In the human UPR caspase 4 substitutes for caspase 12. In yeast and filamentous fungi, the IRE1-XBP-1 (Hac1p/HACA) pathway is the only known UPR signal transduction pathway. \[Reprinted in modified form with permission from Bentham Science Publishers from Schröder M, Kaufman, RJ (2006) Divergent roles of IRE1α and PERK in the unfolded protein response. Curr Mol Med 6:5--36\]

BiP release from ATF6 induces translocation of ATF6 to the Golgi complex where its bZIP transcription factor domain is proteolytically released from the Golgi membrane by site 1 and 2 proteases (S1P and S2P) (Fig. [4](#Fig4){ref-type="fig"}). This cytosolic fragment translocates to the nucleus and induces expression of chaperone genes (Strudwick and Schröder [@CR48]). The functions of the ATF6 paralogs in the ER stress response is less well understood. OASIS contributes to activation of the BiP gene (Kondo et al. [@CR25]), and ATF6·CREB-H heterodimers activate inflammatory genes (Zhang et al. [@CR62]).

BiP release from PERK triggers oligomerization and activation of the protein kinase domain of PERK. PERK phosphorylates the bZIP transcription factor nuclear factor erythroid 2 (NF-E2) related factor 2 (NRF2) and eIF2α (Strudwick and Schröder [@CR48]) (Fig. [4](#Fig4){ref-type="fig"}). NRF2 phosphorylation induces its translocation to the nucleus, where a NRF2·ATF4 heterodimer activates transcription of antioxidant response genes (Harding et al. [@CR13]) to counteract ROS formation by repeated folding attempts of nascent polypeptide chains in ER stressed cells. eIF2α phosphorylation attenuates general translation and decreases the influx of nascent unfolded polypeptide chains into the ER. It also clears short-lived proteins from the cell, i.e. D-type cyclins, resulting in cell cycle arrest in G~1~ phase, and of inhibitors of nuclear factor κB (NF-κB) (IκB), activating the pro-inflammatory transcription factor NF-κB. eIF2α phosphorylation also induces preferential translation of capped mRNAs containing several short upstream open reading frames (uORFs) and cap-independent translation of mRNA *via* internal ribosomal entry sites (IRES). Currently, the only known mRNA whose translation is stimulated by ER stress is the mRNA encoding the bZIP transcription factor ATF4. ATF4 induces expression of CCAAT enhancer binding protein (C/EBP) homologous protein (CHOP)/CHOP-10/growth arrest and DNA damage-inducible gene 153 (GADD153). CHOP represses transcription of anti-apoptotic *BCL*-2 (McCullough et al. [@CR28]) and induces expression of pro-apoptotic *tribbles-related protein* 3 (*TRB*3) (Ohoka et al. [@CR33]). Translational attenuation by PERK is transient and countered by several eIF2α phosphatases. The regulatory subunit of protein phosphatase 1 (PP1), GADD34, is induced late in ER stress by ATF4, and targets PP1 to eIF2α.

Upon BiP release, IRE1 autophosphorylates *in trans* and activates its endoribonuclease domain (Strudwick and Schröder [@CR48]). Activated IRE1 cleaves exon-intron junctions in the mRNAs encoding the bZIP transcription factors homologous to ATF/CREB1 protein (Hac1p) in yeast, HACA in filamentous fungi, and X box-binding protein 1 (XBP-1)/hepatocarcinogenesis-related transcription factor (HTF)/tax-responsive element binding protein 5 (TREB5) in metazoans (Fig. [4](#Fig4){ref-type="fig"}). In yeast, the *HAC1* exons are ligated by transfer RNA ligase. Both transcription factors activate expression of genes encoding ER-resident molecular chaperones, protein foldases, and genes encoding proteins involved in ERAD. Hac1p and XBP-1 also stimulate phospholipid biosynthesis. Spliced Hac1p represses genes under control of the transcriptional regulator unscheduled meiosis 6 protein (Ume6p), including the early meiotic genes and a large array of genes involved in carbon and nitrogen metabolism. This function of spliced Hac1p may explain the slow growth phenotype of yeast cells overexpressing Ire1p or spliced Hac1p (Mori et al. [@CR31]). Attenuation of metabolism by Hac1p in yeast may substitute for attenuation of general translation by PERK. XBP-1 activation is delayed compared to ATF6 and PERK activation (Yoshida et al. [@CR61]), allowing for an early folding only phase in the UPR followed by a folding and degradation phase. In mammals, phosphorylated IRE1 sequesters tumor necrosis factor receptor associated factor 2 (TRAF2) from pro-caspase 12, resulting in clustering and activation of this caspase and initiation of apoptosis (Strudwick and Schröder [@CR48]) (Fig. [4](#Fig4){ref-type="fig"}). TRAF2 recruits apoptosis signal-regulating kinase 1 (ASK1) and IκB kinase to IRE1. ASK1 activates the mitogen-activated protein (MAP) kinases p38 and ju-nana (jun) *N*-terminal kinases (JNKs). p38 and JNKs phosphorylate and potentiate pro-apoptotic transcription factors, i.e. CHOP and c-Jun, and phosphorylate and inhibit anti-apoptotic Bcl-2 and Bcl-x~L~ to induce apoptosis (Szegezdi et al. [@CR49]). Inhibition of JNK phosphatases by ROS formed in oxidative protein folding also contributes to JNK activation (Kamata et al. [@CR21]). Association of the pro-apoptotic Bcl-2 family proteins Bax and Bak with the cytosolic portion of IRE1 is required for efferent IRE1 signaling, i.e. *XBP-1* mRNA splicing and JNK1 activation (Hetz et al. [@CR16]).

Engineering of the UPR {#Sec5}
======================

Engineering of the UPR holds promise to increase concentrations of several chaperones in a functionally meaningful ratio, thus preventing inadvertent conversion of chaperone foldases into holdases, or even inactivating chaperones because of lack of concomitant increases in co-chaperones and co-factors. The UPR is as much a survival response as it is a response to boost protein secretion. Clearly, some aspects of the physiological UPR are not desirable in an expression system, for example inhibition of general translation by PERK, stimulation of ERAD and apoptosis. Overexpression of spliced Hac1p or its filamentous fungi homolog HACA increased heterologous protein secretion in *Saccharomyces cerevisiae* and *Aspergillus niger* (Valkonen et al. [@CR54], [@CR55]). In Chinese hamster ovary (CHO)-K1 cells XBP-1 overexpression improved secretion of several heterologous proteins (Ku et al. [@CR26]; Tigges and Fussenegger [@CR50]). In yeast and filamentous fungi, secretion of several heterologous proteins was not improved or even decreased by overexpression of Hac1p (Gasser et al. [@CR9]; Rakestraw and Wittrup [@CR37]; Valkonen et al. [@CR54]). One drawback of some of these studies is that wild-type (WT) cells with a functional UPR are compared to WT cells overexpressing spliced Hac1p, which may explain why in some cases only marginal differences between the two cell types have been observed. The more consistent effect of spliced XBP-1 overexpression on protein secretion (Ku et al. [@CR26]; Tigges and Fussenegger [@CR50]) may be caused by a preferential activation of UPR signaling pathways that stimulate cellular functions beneficial for heterologous protein secretion, i.e. increased chaperone gene expression. This increased ER-resident chaperone machinery attenuates all UPR signaling, and most importantly, those UPR signaling pathways likely to decrease protein production, for example general translation inhibition by PERK, stimulation of ERAD and of apoptosis (Özcan et al. [@CR35]).

Conclusions {#Sec6}
===========

Engineering of chaperone systems by overexpressing a single component of the ER-resident protein folding machinery has overall yielded mixed results. Our basic understanding of protein folding in the ER is still incomplete. Addressing these open questions should underpin engineering approaches to improve the performance of chaperone systems. A more detailed understanding of chaperone function and regulation should inform future work to improve chaperone systems. Co-expression of different holdases or targeting of heterologous or cytosolic holdases to the ER may yield more consistent improvements for different heterologous proteins. The function of overexpressed chaperones may not be the same as at their normal physiological concentrations, because of the lack of a corresponding increase in co-chaperones and co-factors. To improve foldase function, concomitant elevation of BiP, its co-chaperones, and ATP levels should be attempted.

Engineering of the UPR suggests that mimicking an UPR by expression of its activated signaling molecules does not consistently improve productivities. Dissection of UPR signaling activities may be necessary to improve heterologous protein secretion. To place engineering of the UPR on an informed basis, we need to understand the UPR in more detail. It is still not clear what the most upstream events in activation of the UPR are, how UPR signaling integrates into cellular signaling, and how the UPR decides between a prosurvival and an apoptotic response to ER stress. Cell engineering also needs to address the potential problem that increased oxidative protein folding may be inherently toxic to cells, because of elevated cellular ROS levels.

Work in my group is currently funded by the BBSRC (BB/C513418/1, BB/D01588X/1, and BB/E006035/1), the European Commission (MIRG-CT-2005-016411), the Wellcome Trust (079821), and travel grants from the BBSRC (ISIS 1754) and Royal Society (CG-2005/R4 and CG-2006/R4).
